{"id":10365,"date":"2020-04-21T20:05:00","date_gmt":"2020-04-22T01:05:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/news\/shockwave-medical-to-report-first-quarter-2020-financial-results-on-may-12-2020\/"},"modified":"2020-04-21T20:05:00","modified_gmt":"2020-04-22T01:05:00","slug":"shockwave-medical-to-report-first-quarter-2020-financial-results-on-may-12-2020","status":"publish","type":"news","link":"https:\/\/shockwavemedical.com\/ja\/news\/shockwave-medical-to-report-first-quarter-2020-financial-results-on-may-12-2020\/","title":{"rendered":"Shockwave Medical to Report First Quarter 2020 Financial Results on May 12, 2020"},"content":{"rendered":"\n<section id=\"block_4814759c52a575e41cbd048192420f70\" class=\"block block--wysiwyg wysiwyg_styles u-bgColorNone container\">\n\t<div class=\"u-wysiwyg u-animation\">\n\t\t<p align=\"left\">SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) \u2014 Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will report financial results for the first quarter 2020 after market close on Tuesday, May 12, 2020. Company management will host a corresponding teleconference that will be webcasted live beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p><strong>About Shockwave Medical, Inc.<br \/>\n<\/strong>Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for medical device treatment of atherosclerotic cardiovascular disease through their differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which they refer to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qnAsSinDvm5szJw8PDb3w-I9zlpzgs_-I8vqx8rX3MYu3m0CMPdks-6bi9RK5a1j4viwRrfz-UWtEX-um4hj5LWyDpjQGpSKdUHUrMDoBW8=\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">www.shockwavemedical.com<\/a>.<\/p>\n<p><strong>Media Contact:<br \/>\n<\/strong>Scott Shadiow<br \/>\n+1.317.432.9210<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aLIrIH35PhcoMT0TkCpuVfNAouD0advFfuPiblSsu0BfN-VB5c2BJkxop8VAXVw1OdpUja_4fZi5X4BnX-c68Rnft9_slWHpYVXypZtezrgqY-33ZQxCWlHaXYr7vHM8\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">sshadiow@shockwavemedical.com<\/a><\/p>\n<p><strong>Investor Contact:<br \/>\n<\/strong>Debbie Kaster, Gilmartin Group<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bCnXHpPdC8gKkQkYRiq66N_XUgRLUAMjA5msyssOexFYrB-mrSNCdeFf864b3TF9ENIdg1ipxiQRpGH_Lm2Kg6tUsBX9ySPzynCG7lMHO8xX4XpjO_VGd70mrM4pcxZA\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">investors@shockwavemedical.com<\/a><\/p>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"<p>Shockwave Medical will report financial results for the first quarter 2020 after market close on Tuesday, May 12, 2020.<\/p>\n","protected":false},"featured_media":9944,"template":"","format":[],"meta":{"_acf_changed":true,"content-type":""},"disease-state":[],"news-topic":[],"product-tag":[],"specialty":[],"technology":[],"class_list":["post-10365","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news\/10365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/media\/9944"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/media?parent=10365"}],"wp:term":[{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/disease-state?post=10365"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/format?post=10365"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news-topic?post=10365"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/product-tag?post=10365"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/specialty?post=10365"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/technology?post=10365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}